Jianyu Yang - Concord Medical Chairman
| CCM Stock | USD 0.63 0.07 10.00% |
Chairman
Dr. Jianyu Yang serves as Chairman of the Board, Chief Executive Officer of Concord Medical Services Holdings Ltd. He served as a director of our company and president from 2008 to 2011. Prior to joining our company, Dr. Yang served as chief executive officer of Eguard Resource Development Co., Ltd., a PRC company listed on the Shenzhen Stock Exchange in China principally engaged in the provision of comprehensive solutions in recycling, reuse of solid wastes and wastewater since 2003, vice president of Beijing Sound Environmental Group Co. Ltd. from 2002 to 2003, assistant to the general manager of Xiangcai Securities Co., Ltd. from 2000 to 2002, and senior economist at China Agricultural Bank from 1999 to 2000 since 2011.
| Age | 53 |
| Tenure | 13 years |
| Professional Marks | Ph.D |
| Address | Tower A, Global Trade Center, Beijing, China, 100013 |
| Phone | 86 10 5903 6688 |
| Web | https://www.concordmedical.com |
Concord Medical Management Efficiency
The company has Return on Asset of (0.048) % which means that on every $100 spent on assets, it lost $0.048. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2823) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of May 2024, Return On Equity is likely to grow to 0.18, while Return On Tangible Assets are likely to drop (0.07). At this time, Concord Medical's Other Current Assets are very stable compared to the past year. As of the 3rd of May 2024, Total Current Assets is likely to grow to about 741.5 M, while Other Assets are likely to drop about 26.2 M.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Daniel McCartney | Healthcare Services Group | 63 | |
Management Performance
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.048 |
Concord Medical Services Leadership Team
Elected by the shareholders, the Concord Medical's board of directors comprises two types of representatives: Concord Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Concord. The board's role is to monitor Concord Medical's management team and ensure that shareholders' interests are well served. Concord Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Concord Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xun Liu, Financial Controller | ||
| Shangyan Chuang, Director | ||
| Matthew Callister, Chief Medical Officer | ||
| Zhang Liping, Independent Director | ||
| Shang Chuang, Director | ||
| Jianyu Yang, Chairman, CEO, Chairman of Compensation Committee and Member of Investment Committee | ||
| Boxun Zhang, Independent Director | ||
| Jing Zhang, Chief Administrative Officer | ||
| Weibo Yin, Independent Director and Member of Audit Committee | ||
| William Zima, IR Contact Officer | ||
| Jigang Sun, Chief Investment Officer and Chairman of Investment Committee | ||
| Yue Yu, Director | ||
| Sui Yan, Director | ||
| Zheng Cheng, President, Director and Member of Investment Committee | ||
| Qing Pan, Director | ||
| Elaine Zong, Independent Director | ||
| Yongjun Li, Independent Director | ||
| Fu Xiao, Chief Operating Officer | ||
| Yaw Yap, CFO and Member of Investment Committee | ||
| Ting Lee, Independent Non-Executive Director | ||
| Liping Zhang, Independent Director | ||
| Tian Ji, Independent Director | ||
| Zhe Yin, Independent Director |
Concord Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Concord Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.048 | ||||
| Profit Margin | (0.55) % | ||||
| Operating Margin | (0.98) % | ||||
| Current Valuation | 7.2 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.10 % | ||||
| Number Of Shares Shorted | 6.93 K | ||||
| Price To Earning | (3.90) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.
Pair Trading with Concord Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Concord Stock
| 0.82 | RCM | R1 RCM Inc | PairCorr |
| 0.74 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.65 | FORA | Forian Inc Financial Report 10th of May 2024 | PairCorr |
| 0.65 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.64 | EVH | Evolent Health Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.